+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In Vitro Diagnostics (IVD) Market by Product Type, Technique, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4730305
  • Report
  • December 2018
  • Region: Global
  • 377 pages
  • Allied Analytics LLP
1 of 4
IVD Market Overview:

The global in vitro diagnostics (IVD) market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025.

In vitro diagnostic (IVD) is a technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point of care. Some of the significant technologies incorporated in IVD include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product type design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.

Rise in need for IVD testing arises due to increase in incidences of chronic and infectious diseases and growth in geriatric population prone to immunological disorders. Moreover, advancements in personalized medicines and widespread knowledge of rare diseases are expected to boost the growth of the global IVD market. In addition, increase in incidences of colorectal cancer, neurological disorders, and gynecological diseases are anticipated to boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavorable reimbursement policies are expected to restrain the growth of the global market.

The report segments the market across different categories such as product type, technique, application, end users, and region. Based on product type, the market is segmented into reagents, instruments, and services & software.
Based on techniques, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. The immunodiagnostics is further segmented into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. The ELISA segment is further classified into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Molecular diagnostics segment is further divided into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarrays, and others. Similarly, clinical chemistry segment is categorized into basic metabolic panel, liver panel, lipid profile, thyroid function panel, renal profile, electrolyte panel, and specialty chemicals.

By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is divided into hospitals, academic & medical schools, point of care testing, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key players profiled in the report include Abbott Laboratories; Becton, Dickinson and Company; bioMérieux SA, Bio-Rad Laboratories, Inc.; Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Johnson & Johnson; QIAGEN N.V.; Sysmex Corporation; and Thermo Fisher Scientific, Inc.

Key Benefits for IVD Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

IVD Key Market Segments:

By Product Type

Reagents
Instruments
Software & Services

By Techniques

Immunodiagnostics
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassays (CLIAS)
Fluorescence Immunoassays (FIAS)
Colorimetric Immunoassays (CIS)
Rapid Tests
Enzyme-Linked ImmunoSpot Assays (ELISPOT)
Radioimmunoassay
Western Blot
Hematology

Molecular Diagnostics
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Hybridization

DNA Diagnostics
Microarrays
Others

Tissue Diagnostics
Clinical Chemistry
Basic Metabolic Panel
Liver Panel
Lipid Profile
Thyroid Function Panel
Renal Profile
Electrolyte Panel
Specialty Chemicals

Other IVD Techniques

By End User

Standalone Laboratory
Hospitals
Academic & Medical Schools
Point of Care Testing
Others

By Region

North America
U.S.
Canada
Mexico

Europe
Germany
France
UK
Italy
Spain
Rest of Europe

Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific

LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

List Of Key Players Profiled in the Report

Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
QIAGEN N.V.
Sysmex Corporation
Thermo Fisher Scientific, Inc.

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)

Illumina, Inc.
Luminex Corporation.
Siemens Healthcare GmbH.
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies, 2017
3.4. Top player positioning, 2017
3.5. Porters five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in incidence of chronic and infectious diseases
3.6.1.2. Technological advancements in IVD
3.6.1.3. Emergence of minimal invasive technologies
3.6.1.4. Increasing government expenditures on healthcare
3.6.1.5. Increase in popularity of personalized medicine approach
3.6.2. Restraint
3.6.2.1. Unclear reimbursement policies
3.6.2.2. Stringent regulatory policies
3.6.3. Opportunities
3.6.3.1. Potential opportunities for outsourcing
3.6.3.2. Convergence of new technologies
3.6.4. Impact Analyses

CHAPTER 4: IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

CHAPTER 5: IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Immunodiagnostics
5.2.1. Market size and forecast, by type
5.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.1.1.1. Market size and forecast
5.2.1.1.2. Chemiluminescence Immunoassay (CLIA)
5.2.1.1.2.1. Market size and forecast
5.2.1.1.3. Fluorescence Immunoassay (FIA)
5.2.1.1.3.1. Market size and forecast
5.2.1.1.4. Colorimetric Immunoassay (CI)
5.2.1.1.4.1. Market size and forecast
5.2.1.2. Rapid Tests
5.2.1.2.1. Market size and forecast
5.2.1.3. Enzyme-Linked ImmunoSpot (ELISPOT)
5.2.1.3.1. Market size and forecast
5.2.1.4. Radioimmunoassay (RIA)
5.2.1.4.1. Market size and forecast
5.2.1.5. Western Blot
5.2.1.5.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Hematology
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Molecular Diagnostics
5.4.1. Market size and forecast, by type
5.4.1.1. Polymerize Chain Reaction (PCR)
5.4.1.1.1. Market size and forecast
5.4.1.2. Isothermal Nucleic Acid Technology (INAAT)
5.4.1.2.1. Market size and forecast
5.4.1.3. Hybridization
5.4.1.3.1. Market size and forecast
5.4.1.4. DNA Diagnostics
5.4.1.4.1. Market size and forecast
5.4.1.5. Microarray
5.4.1.5.1. Market size and forecast
5.4.1.6. Others
5.4.1.6.1. Market size and forecast
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis, by country
5.5. Tissue Diagnostics
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Clinical Chemistry
5.6.1. Market size and forecast, by type
5.6.1.1. Basic Metabolic Panel
5.6.1.1.1. Market size and forecast
5.6.1.2. Liver Panel
5.6.1.2.1. Market size and forecast
5.6.1.3. Renal Profile
5.6.1.3.1. Market size and forecast
5.6.1.4. Lipid Profile
5.6.1.4.1. Market size and forecast
5.6.1.5. Thyroid Function Panel
5.6.1.5.1. Market size and forecast
5.6.1.6. Electrolyte Panel
5.6.1.6.1. Market size and forecast
5.6.1.7. Specialty Chemicals
5.6.1.7.1. Market size and forecast
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis, by country
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis, by country

CHAPTER 6: IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Infectious Diseases
6.2.1. Market size and forecast, by region
6.2.2. Market share analysis
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Cardiac Diseases
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Immune System Disorders
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Nephrological Diseases
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis
6.7. Gastrointestinal Diseases
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis
6.8. Others
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis

CHAPTER 7: IN-VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Stand-Alone Laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Hospitals
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Academic & Medical Schools
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Point of Care Testing
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
7.6. Others
7.6.1. Market size and forecast, by region
7.6.2. Market share analysis, by country

CHAPTER 8: IN-VITRO DIAGNOSTICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. In-vitro diagnostics market, by product type
8.2.2.1.2. U.S. In-vitro diagnostics market, by technique
8.2.2.1.3. U.S. In-vitro diagnostics market, by application
8.2.2.1.4. U.S. In-vitro diagnostics market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada In-vitro diagnostics market, by product type
8.2.2.2.2. Canada In-vitro diagnostics market, by technique
8.2.2.2.3. Canada In-vitro diagnostics market, by application
8.2.2.2.4. Canada In-vitro diagnostics market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico In-vitro diagnostics market, by product type
8.2.2.3.2. Mexico In-vitro diagnostics market, by technique
8.2.2.3.3. Mexico In-vitro diagnostics market, by application
8.2.2.3.4. Mexico In-vitro diagnostics market, by end user
8.2.3. Market size and forecast, by product type
8.2.4. Market size and forecast, by technique
8.2.5. Market size and forecast, by application
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany
8.3.2.1.1. Germany In-vitro diagnostics market, by product type
8.3.2.1.2. Germany In-vitro diagnostics market, by technique
8.3.2.1.3. Germany In-vitro diagnostics market, by application
8.3.2.1.4. Germany In-vitro diagnostics market, by end user
8.3.2.2. France
8.3.2.2.1. France In-vitro diagnostics market, by product type
8.3.2.2.2. France In-vitro diagnostics market, by technique
8.3.2.2.3. France In-vitro diagnostics market, by application
8.3.2.2.4. France In-vitro diagnostics market, by end user
8.3.2.3. UK
8.3.2.3.1. UK In-vitro diagnostics market, by product type
8.3.2.3.2. UK In-vitro diagnostics market, by technique
8.3.2.3.3. UK In-vitro diagnostics market, by application
8.3.2.3.4. UK In-vitro diagnostics market, by end user
8.3.2.4. Italy
8.3.2.4.1. Italy In-vitro diagnostics market, by product type
8.3.2.4.2. Italy In-vitro diagnostics market, by technique
8.3.2.4.3. Italy In-vitro diagnostics market, by application
8.3.2.4.4. Italy In-vitro diagnostics market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain In-vitro diagnostics market, by product type
8.3.2.5.2. Spain In-vitro diagnostics market, by technique
8.3.2.5.3. Spain In-vitro diagnostics market, by application
8.3.2.5.4. Spain In-vitro diagnostics market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe In-vitro diagnostics market, by product t type
8.3.2.6.2. Rest of Europe In-vitro diagnostics market, by technique
8.3.2.6.3. Rest of Europe In-vitro diagnostics market, by application
8.3.2.6.4. Rest of Europe In-vitro diagnostics market, by end user
8.3.3. Market size and forecast, by product type
8.3.4. Market size and forecast, by technique
8.3.5. Market size and forecast, by application
8.3.6. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan
8.4.2.1.1. Japan In-vitro diagnostics market, by product type
8.4.2.1.2. Japan In-vitro diagnostics market, by technique
8.4.2.1.3. Japan In-vitro diagnostics market, by application
8.4.2.1.4. Japan In-vitro diagnostics market, by end user
8.4.2.2. China
8.4.2.2.1. China In-vitro diagnostics market, by product type
8.4.2.2.2. China In-vitro diagnostics market, by technique
8.4.2.2.3. China In-vitro diagnostics market, by application
8.4.2.2.4. China In-vitro diagnostics market, by end user
8.4.2.3. Australia
8.4.2.3.1. Australia In-vitro diagnostics market, by product type
8.4.2.3.2. Australia In-vitro diagnostics market, by technique
8.4.2.3.3. Australia In-vitro diagnostics market, by application
8.4.2.3.4. Australia In-vitro diagnostics market, by end user
8.4.2.4. India
8.4.2.4.1. India In-vitro diagnostics market, by product type
8.4.2.4.2. India In-vitro diagnostics market, by technique
8.4.2.4.3. India In-vitro diagnostics market, by application
8.4.2.4.4. India In-vitro diagnostics market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea In-vitro diagnostics market, by product type
8.4.2.5.2. South Korea In-vitro diagnostics market, by technique
8.4.2.5.3. South Korea In-vitro diagnostics market, by application
8.4.2.5.4. South Korea In-vitro diagnostics market, by end user
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific In-vitro diagnostics market, by product type
8.4.2.6.2. Rest of Asia-Pacific In-vitro diagnostics market, by technique
8.4.2.6.3. Rest of Asia-Pacific In-vitro diagnostics market, by application
8.4.2.6.4. Rest of Asia-Pacific In-vitro diagnostics market, by end user
8.4.3. Market size and forecast, by product type
8.4.4. Market size and forecast, by technique
8.4.5. Market size and forecast, by indication
8.4.6. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil In-vitro diagnostics market, by product type
8.5.2.1.2. Brazil In-vitro diagnostics market, by technique
8.5.2.1.3. Brazil In-vitro diagnostics market, by application
8.5.2.1.4. Brazil In-vitro diagnostics market, by end user
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia In-vitro diagnostics market, by product type
8.5.2.2.3. Saudi Arabia In-vitro diagnostics market, by technique
8.5.2.2.4. Saudi Arabia In-vitro diagnostics market, by application
8.5.2.2.5. Saudi Arabia In-vitro diagnostics market, by end user
8.5.2.3. South Africa
8.5.2.3.1. South Africa In-vitro diagnostics market, by product type
8.5.2.3.2. South Africa In-vitro diagnostics market, by technique
8.5.2.3.3. South Africa In-vitro diagnostics market, by application
8.5.2.3.4. South Africa In-vitro diagnostics market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA In-vitro diagnostics market, by product type
8.5.2.4.2. Rest of LAMEA In-vitro diagnostics market, by technique
8.5.2.4.3. Rest of LAMEA In-vitro diagnostics market, by application
8.5.2.4.4. Rest of LAMEA In-vitro diagnostics market, by end user
8.5.3. Market size and forecast, by product type
8.5.4. Market size and forecast, by technique
8.5.5. Market size and forecast, by application
8.5.6. Market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. Becton, Dickinson and Company
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. bioMrieux SA
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product type portfolio
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product type Portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Danaher Corporation (Beckman Coulter, Inc.)
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product type portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. F. Hoffmann-La Roche Ltd.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product type portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Johnson & Johnson
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product type Portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. QIAGEN N.V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Sysmex Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product type Portfolio
9.9.5. Business performance
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product type Portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments

List Of Tables

Table 01. Global In-Vitro Diagnostics Market, By Product Type, 2017-2025 ($Million)
Table 02. In-Vitro Diagnostics Market For Reagents, By Region, 20162023 ($Million)
Table 03. In-Vitro Diagnostics Market For Instruments, By Region, 2017-2025 ($Million)
Table 04. In-Vitro Diagnostics Market For Software And Services, By Region, 2017-2025 ($Million)
Table 05. Global In-Vitro Diagnostics Market, By Technique, 2017-2025 ($Million)
Table 06. In-Vitro Diagnostics Market For Immuno-Diagnostics, By Type, 2017-2025 ($Million)
Table 07. In-Vitro Diagnostics Market For Elisa, By Type 2017-2025 ($Million)
Table 08. In-Vitro Diagnostics Market For Immuno-Diagnostics, By Region, 2017-2025 ($Million)
Table 09. In-Vitro Diagnostics Market For Hematology, By Region, 2017-2025 ($Million)
Table 10. Molecular Diagnostics Market, By Type, 2017-2025 ($Million)
Table 11. In-Vitro Diagnostics Market For Molecular Diagnostics, By Region, 2017-2025 ($Million)
Table 12. In-Vitro Diagnostics Market For Tissue Diagnostics, By Region, 2017-2025 ($Million)
Table 13. Clinical Chemistry Market, By Type, 2017-2025 ($Million)
Table 14. In-Vitro Diagnostics Market For Clinical Chemistry, By Region, 2017-2025 ($Million)
Table 15. In-Vitro Diagnostics Market For Other Ivd Techniques, By Region, 2017-2025 ($Million)
Table 16. Global In-Vitro Diagnostics Market, By Indication, 2017-2025 ($Million)
Table 17. In-Vitro Diagnostics Market For Infectious Diseases, By Region,2017-2025 ($Million)
Table 18. In-Vitro Diagnostics Market For Cancer, By Region, 2017-2025 ($Million)
Table 19. In-Vitro Diagnostics Market For Cardiac Diseases, By Region, 2017-2025 ($Million)
Table 20. In-Vitro Diagnostics Market For Immune System Disorders, By Region, 2017-2025 ($Million)
Table 21. In-Vitro Diagnostics Market For Nephrological Diseases, By Region, 2017-2025 ($Million)
Table 22. In-Vitro Diagnostics Market For Gastrointestinal Diseases, By Region, 2017-2025 ($Million)
Table 23. In-Vitro Diagnostics Market For Other Indications, By Region, 2017-2025 ($Million)
Table 24. Global In-Vitro Diagnostics Market, By End User, 2017-2025 ($Million)
Table 25. In-Vitro Diagnostics Market For Stand-Alone Laboratory, By Region, 2017-2025 ($Million)
Table 26. In-Vitro Diagnostics Market For Hospitals, By Region, 2017-2025 ($Million)
Table 27. In-Vitro Diagnostics Market For Academic And Medical Schools, By Region, 2017-2025 ($Million)
Table 28. In-Vitro Diagnostics Market For Point Of Care Testing, By Region, 2017-2025 ($Million)
Table 29. In-Vitro Diagnostics Market For Others, By Region, 2017-2025 ($Million)
Table 30. In-Vitro Diagnostics Market Revenue, By Region, 2017-2025 ($Million)
Table 31. North America In-Vitro Diagnostics Market, By Country, 2017-2025 ($Million)
Table 32. U.S. In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 33. U.S. In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 34. U.S. In-Vitro Diagnostics Market, By Application, 2017-2025
Table 35. U.S. In-Vitro Diagnostics Market, By End User, 2017-2025
Table 36. Canada In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 37. Canada In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 38. Canada In-Vitro Diagnostics Market, By Application, 2017-2025
Table 39. Canada In-Vitro Diagnostics Market, By End User, 2017-2025
Table 40. Mexico In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 41. Mexico In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 42. Mexico In-Vitro Diagnostics Market, By Application, 2017-2025
Table 43. Mexico In-Vitro Diagnostics Market, By End User, 2017-2025
Table 44. North America In-Vitro Diagnostics Market, By Product Type, 2017-2025 ($Million)
Table 45. North America In-Vitro Diagnostics Market, By Technique, 2017-2025 ($Million)
Table 46. North America In-Vitro Diagnostics Market, By Application, 2017-2025 ($Million)
Table 47. North America In-Vitro Diagnostics Market, By End User, 2017-2025 ($Million)
Table 48. Europe In-Vitro Diagnostics Market, By Country, 2017-2025 ($Million)
Table 49. Germany In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 50. Germany In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 51. Germany In-Vitro Diagnostics Market, By Application, 2017-2025
Table 52. Germany In-Vitro Diagnostics Market, By End User, 2017-2025
Table 53. France In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 54. France In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 55. France In-Vitro Diagnostics Market, By Application, 2017-2025
Table 56. France In-Vitro Diagnostics Market, By End User, 2017-2025
Table 57. Uk In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 58. Uk In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 59. Uk In-Vitro Diagnostics Market, By Application, 2017-2025
Table 60. Uk In-Vitro Diagnostics Market, By End User, 2017-2025
Table 61. Italy In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 62. Italy In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 63. Italy In-Vitro Diagnostics Market, By Application, 2017-2025
Table 64. Italy In-Vitro Diagnostics Market, By End User, 2017-2025
Table 65. Spain In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 66. Spain In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 67. Spain In-Vitro Diagnostics Market, By Application, 2017-2025
Table 68. Spain In-Vitro Diagnostics Market, By End User, 2017-2025
Table 69. Rest Of Europe In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 70. Rest Of Europe In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 71. Rest Of Europe In-Vitro Diagnostics Market, By Application, 2017-2025
Table 72. Rest Of Europe In-Vitro Diagnostics Market, By End User, 2017-2025
Table 73. Europe In-Vitro Diagnostics Market, By Product Type, 2017-2025 ($Million)
Table 74. Europe In-Vitro Diagnostics Market, By Technique, 2017-2025 ($Million)
Table 75. Europe In-Vitro Diagnostics Market, By Application, 2017-2025 ($Million)
Table 76. Europe In-Vitro Diagnostics Market, By End User, 2017-2025 ($Million)
Table 77. Asia-Pacific In-Vitro Diagnostics Market, By Country, 2017-2025 ($Million)
Table 78. Japan In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 79. Japan In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 80. Japan In-Vitro Diagnostics Market, By Application, 2017-2025
Table 81. Japan In-Vitro Diagnostics Market, By End User, 2017-2025
Table 82. China In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 83. China In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 84. China In-Vitro Diagnostics Market, By Application, 2017-2025
Table 85. China In-Vitro Diagnostics Market, By End User, 2017-2025
Table 86. Australia In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 87. Australia In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 88. Australia In-Vitro Diagnostics Market, By Application, 2017-2025
Table 89. Australia In-Vitro Diagnostics Market, By End User, 2017-2025
Table 90. India In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 91. India In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 92. India In-Vitro Diagnostics Market, By Application, 2017-2025
Table 93. India In-Vitro Diagnostics Market, By End User, 2017-2025
Table 94. South Korea In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 95. South Korea In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 96. South Korea In-Vitro Diagnostics Market, By Application, 2017-2025
Table 97. South Korea In-Vitro Diagnostics Market, By End User, 2017-2025
Table 98. Rest Of Asia-Pacific In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 99. Rest Of Asia-Pacific In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 100. Rest Of Asia-Pacific In-Vitro Diagnostics Market, By Application, 2017-2025
Table 101. Rest Of Asia-Pacific In-Vitro Diagnostics Market, By End User, 2017-2025
Table 102. Asia-Pacific In-Vitro Diagnostics Market, By Product Type, 2017-2025 ($Million)
Table 103. Asia-Pacific In-Vitro Diagnostics Market, By Technique, 2017-2025 ($Million)
Table 104. Asia-Pacific In-Vitro Diagnostics Market, By Indication, 2017-2025 ($Million)
Table 105. Asia-Pacific In-Vitro Diagnostics Market, By End User, 2017-2025 ($Million)
Table 106. Lamea In-Vitro Diagnostics Market, By Country, 2017-2025 ($Million)
Table 107. Brazil In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 108. Brazil In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 109. Brazil In-Vitro Diagnostics Market, By Application, 2017-2025
Table 110. Brazil In-Vitro Diagnostics Market, By End User, 2017-2025
Table 111. Saudi Arabia In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 112. Saudi Arabia In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 113. Saudi Arabia In-Vitro Diagnostics Market, By Application, 2017-2025
Table 114. Saudi Arabia In-Vitro Diagnostics Market, By End User, 2017-2025
Table 115. South Africa In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 116. South Africa In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 117. South Africa In-Vitro Diagnostics Market, By Application, 2017-2025
Table 118. South Africa In-Vitro Diagnostics Market, By End User, 2017-2025
Table 119. Rest Of Lamea In-Vitro Diagnostics Market, By Product Type, 2017-2025
Table 120. Rest Of Lamea In-Vitro Diagnostics Market, By Technique, 2017-2025
Table 121. Rest Of Lamea In-Vitro Diagnostics Market, By Application, 2017-2025
Table 122. Rest Of Lamea In-Vitro Diagnostics Market, By End User, 2017-2025
Table 123. Lamea In-Vitro Diagnostics Market, By Product Type, 2017-2025 ($Million)
Table 124. Lamea In-Vitro Diagnostics Market, By Technique, 2017-2025 ($Million)
Table 125. Lamea In-Vitro Diagnostics Market, By Application, 2017-2025 ($Million)
Table 126. Lamea In-Vitro Diagnostics Market, By End User, 2017-2025 ($Million)
Table 127. Abbott: Company Snapshot
Table 128. Abbott: Operating Segments
Table 129. Abbott: Product Type Portfolio
Table 130. Bd : Company Snapshot
Table 131. Bd : Operating Segments
Table 132. Bd : Product Type Portfolio
Table 133. Biomrieux: Company Snapshot
Table 134. Biomrieux: Product Type Portfolio
Table 135. Bio-Rad: Company Snapshot
Table 136. Bio-Rad: Operating Segments
Table 137. Bio-Rad: Product Type Portfolio
Table 138. Danaher: Company Snapshot
Table 139. Danaher: Operating Segments
Table 140. Danaher: Product Type Portfolio
Table 141. Roche: Company Snapshot
Table 142. Roche: Operating Segments
Table 143. Roche: Product Type Portfolio
Table 144. J&J: Company Snapshot
Table 145. J&J: Operating Segments
Table 146. J&J: Product Type Portfolio
Table 147. Qiagen: Company Snapshot
Table 148. Qiagen: Product Type Portfolio
Table 149. Sysmex: Company Snapshot
Table 150. Sysmex: Product Type Portfolio
Table 151. Thermo Fisher Scientific: Company Snapshot
Table 152. Thermo Fisher Scientific: Operating Segments
Table 153. Thermo Fisher Scientific: Product Type Portfolio

List Of Figures

Figure 01. In-Vitro Diagnostics Market Segmentation
Figure 02. Top Investment Pockets
Figure 03. Top Winning Strategies, 2015-2018
Figure 04. Figure 4. Top Winning Strategies: Nature And Type, 2015-2018
Figure 05. Top Player Positioning, 2017
Figure 06. Moderate Barganing Power Of Buyers
Figure 07. High Barganing Power Of Suppliers
Figure 08. Moderate Threat Of Substitution
Figure 09. Low Threat Of New Entrants
Figure 10. High Competitive Rivalry
Figure 11. Impact Analyses, In-Vitro Diagnostics Market
Figure 12. Comparative Analysis Of In-Vitro Diagnostics Market For Reagents, By Country, 2017 & 2025
Figure 13. Comparative Analysis Of In-Vitro Diagnostics Market For Instruments, By Country, 2017 & 2025
Figure 14. Comparative Analysis Of In-Vitro Diagnostics Market For Software And Services, By Country, 2017 & 2025
Figure 15. Chemiluminescence Immunoassay (Clia) Market, 2017-2025 ($Million)
Figure 16. Fluoresence Immunoassay (Fia) Market, 2017-2025 ($Million)
Figure 17. Colorimetric Immunoassays (Ci) Market, 2017-2025 ($Million)
Figure 18. Immuno-Diagnostics Market For Rapid Tests, 2017-2025 ($Million)
Figure 19. Immuno-Diagnostics Market For Enzyme-Linked Immunospot (Elispot), 2017-2025 ($Million)
Figure 20. Immuno-Diagnostics Market For Radioimmunoassays (Ria), 2017-2025 ($Million)
Figure 21. Immuno-Diagnostics Market For Western Blot, 2017-2025 ($Million)
Figure 22. Comparative Analysis Of In-Vitro Diagnostics Market For Immuno-Diagnostics, By Country, 2017 & 2025
Figure 23. Comparative Analysis Of In-Vitro Diagnostics Market For Hematology, By Country, 2017 & 2025
Figure 24. Molecular Diagnostics Market For Polymerize Chain Reaction (Pcr), 2017-2025 ($Million)
Figure 25. Molecular Diagnostics Market For Isothermal Nucleic Acid Technology (Inaat), 2017-2025 ($Million)
Figure 26. Molecular Diagnostics Market For Hybridization, 2017-2025 ($Million)
Figure 27. Molecular Diagnostics Market For Dna Diagnostics, 2017-2025 ($Million)
Figure 28. Molecular Diagnostics Market For Microarray, 2017-2025 ($Million)
Figure 29. Molecular Diagnostics Market For Others, 2017-2025 ($Million)
Figure 30. Comparative Analysis Of In-Vitro Diagnostics Market For Molecular Diagnostics, By Country, 2017 & 2025
Figure 31. Comparative Analysis Of In-Vitro Diagnostics Market For Tissue Diagnostics, By Country, 2017 & 2025
Figure 32. Clinical Chemistry Market For Basic Metabolic Panel, 2017-2025 ($Million)
Figure 33. Clinical Chemistry Market For Liver Panel, 2017-2025 ($Million)
Figure 34. Clinical Chemistry Market For Renal Profile, 2017-2025 ($Million)
Figure 35. Clinical Chemistry Market For Lipid Profile, 2017-2025 ($Million)
Figure 36. Clinical Chemistry Market For Thyroid Function Panel, 2017-2025 ($Million)
Figure 37. Clinical Chemistry Market For Electrolyte Panel, 2017-2025 ($Million)
Figure 38. Clinical Chemistry Market For Specialty Chemicals, 2017-2025 ($Million)
Figure 39. Comparative Analysis Of In-Vitro Diagnostics Market For Clinical Chemistry, By Country, 2017 & 2025
Figure 40. Comparative Analysis Of In-Vitro Diagnostics Market For Other Ivd Techniques, By Country, 2017 & 2025
Figure 41. Comparative Analysis Of In-Vitro Diagnostics Market For Infectious Diseases, By Country, 2017 & 2025
Figure 42. Comparative Analysis Of In-Vitro Diagnostics Market For Cancer, By Country, 2017 & 2025
Figure 43. Comparative Analysis Of In-Vitro Diagnostics Market For Cardiac Diseases, By Country, 2017 & 2025
Figure 44. Comparative Analysis Of In-Vitro Diagnostics Market For Immune System Disorders, By Country, 2017 & 2025
Figure 45. Comparative Analysis Of In-Vitro Diagnostics Market For Nephrological Diseases, By Country, 2017 & 2025
Figure 46. Comparative Analysis Of In-Vitro Diagnostics Market For Gastrointestinal Diseases, By Country, 2017 & 2025
Figure 47. Comparative Analysis Of In-Vitro Diagnostics Market For Other Indications, By Country, 2017 & 2025
Figure 48. Comparative Analysis Of In-Vitro Diagnostics Market For Stand-Alone Laboratory, By Country, 2017 & 2025
Figure 49. Comparative Analysis Of In-Vitro Diagnostics Market For Hospitals, By Country, 2017 & 2025
Figure 50. Comparative Analysis Of In-Vitro Diagnostics Market For Academic And Medical Schools, By Country, 2017 & 2025
Figure 51. Comparative Analysis Of In-Vitro Diagnostics Market For Point Of Care Testing, By Country, 2017 & 2025
Figure 52. Comparative Analysis Of In-Vitro Diagnostics Market For Others, By Country, 2017 & 2025
Figure 53. European Geriatric Population (Above 65 Years), 2017
Figure 54. Abbott: Net Sales, 20152017 ($Million)
Figure 55. Abbott: Net Sales Share, By Operating Segment, 2017 (%)
Figure 56. Abbott: Net Sales Share, By Geography, 2017 (%)
Figure 57. Bd: Revenue, 20152017 ($Million)
Figure 58. Bd: Revenue Share By Segment, 2017 (%)
Figure 59. Bd: Revenue Share By Region, 2017 (%)
Figure 60. Biomrieux: Net Sales, 20152017 ($Million)
Figure 61. Biomrieux: Revenue Share By Geography, 2017 (%)
Figure 62. Bio-Rad: Net Sales, 20152017 ($Million)
Figure 63. Bio-Rad: Revenue Share By Segment, 2017 (%)
Figure 64. Bio-Rad: Revenue Share By Geography, 2017 (%)
Figure 65. Danaher: Net Sales, 20152017 ($Million)
Figure 66. Danaher: Revenue Share By Segment, 2017 (%)
Figure 67. Danaher: Revenue Share By Geography, 2017 (%)
Figure 68. Roche: Net Sales, 20152017 ($Million)
Figure 69. Roche: Revenue Share By Segment, 2017 (%)
Figure 70. Roche: Revenue Share By Geography, 2017 (%)
Figure 71. J&J: Revenue, 20152017 ($Million)
Figure 72. J&J: Revenue Share By Segment, 2017 (%)
Figure 73. J&J: Revenue Share By Geography, 2017 (%)
Figure 74. Qiagen: Net Sales, 20152017 ($Million)
Figure 75. Qiagen: Revenue Share By Product Type, 2017 (%)
Figure 76. Qiagen: Revenue Share By Geography, 2017 (%)
Figure 77. Sysmex: Revenue, 20152017 ($Million)
Figure 78. Sysmex: Revenue Share, By Geography, 2017 (%)
Figure 79. Thermo Fisher Scientific: Revenue, 20152017 ($Million)
Figure 80. Thermo Fisher Scientific: Revenue Share, By Segment, 2017 (%)
Figure 81. Thermo Fisher Scientific: Revenue Share, By Geography, 2017 (%)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, 'In Vitro Diagnostics Market by Product Type, Techniques, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the market was valued at $64,479 million in 2017, and is projected to reach $93,614 million by 2025, growing at a CAGR of 4.8% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

In vitro diagnostics (IVD) field has evolved with technological advancements in the diagnostic techniques and awareness about healthcare in the emerging market. IVD has a wide range of applications in the diagnosis of various diseases such as infectious diseases, diabetes, oncology/cancer, cardiology diseases, autoimmune diseases, nephrology, and HIV/AIDS.

Increase in awareness about healthcare, rise in incidence of chronic and infectious disease, and cost-effective diagnostic solutions fuel the market growth. Similarly, increase in use of automated instruments & point-of-care diagnostic solutions, rise in government expenditure on healthcare in all the regions (North America, Europe, Asia-Pacific, and LAMEA), and accurate and faster test results are expected to boost the growth of the global IVD market. On the contrary, stringent regulations, policies, and unclear reimbursement rules are anticipated to restrain the market growth.

Based on product type, the reagents segment accounted the highest market share in 2017 due to the large number of reagents introduced in the market for the diagnosis of medical conditions using IVD process.
Based on techniques, the immunodiagnostics segment contributed the highest market share in 2017 due to the increase in usage of immunodiagnostics as these tests are the oldest and highly used techniques for the diagnosis infectious diseases, oncology detection, HIV/AIDS virus detection, and others.

Based on application, the infectious diseases segment contributed the highest market share in 2017 due to increase in prevalence of infectious diseases and rise in awareness of preventive health measures.

Key Findings of the In Vitro Diagnostics Market:

North America occupied nearly one-thirds share of the global IVD market in 2017.
The instruments segment is anticipated to grow with the highest CAGR throughout the forecast period.
The immunodiagnostics segment accounted for around one-third share of the global IVD market in 2017.
Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

North America is expected to be the leading regional market for IVD through 2025 due to its well-penetrated healthcare system and higher healthcare awareness among the patients, including Obamas Affordable Care Act (ACA), change in technology, and rebounding American Economy. However, Asia-Pacific is expected to grow at the highest CAGR of 5.9% from 2018 to 2025 due to significant increase in the number of well-equipped hospitals with advanced healthcare systems to cater the needs of the large patient population.

The report provides an extensive competitive analysis and profiles of the key market players such as Abbott Laboratories, Becton, Dickinson and Company, bioMrieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Johnson & Johnson, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll